Nuzenio

Sibeprenlimab

Sibeprenlimab news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 3 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study - Slideshow (OTCMKTS:OTSKY) 2026-08-06 - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 12:44:51 GMTSibeprenlimab (Voyxact) Stabilizes Kidney Function in IgAN - HCPLiveHCPLive · Tue, 04 Aug 2026 15:04:13 GMTIn a first, Otsuka’s Voyxact stabilizes IgAN patients’ kidney function decline to normal levels - Fierce PharmaFierce Pharma · Mon, 03 Aug 2026 21:00:00 GMTOtsuka Unveils Unprecedented Phase 3 VISIONARY Two-Year eGFR Results Demonstrating VOYXACT® (sibeprenlimab-szsi) Stabilizes Kidney Function Decline to Baseline Physiologic Rate, Fundamentally Altering Disease Progression in IgA Nephropathy - Business WireBusiness Wire · Mon, 03 Aug 2026 21:00:00 GMT

Timeline

Thu, 06 Aug 2026 12:44:51 GMTOtsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study - Slideshow (OTCMKTS:OTSKY) 2026-08-06 - Seeking Alpha
Tue, 04 Aug 2026 15:04:13 GMTSibeprenlimab (Voyxact) Stabilizes Kidney Function in IgAN - HCPLive
Mon, 03 Aug 2026 21:00:00 GMTIn a first, Otsuka’s Voyxact stabilizes IgAN patients’ kidney function decline to normal levels - Fierce Pharma
Mon, 03 Aug 2026 21:00:00 GMTOtsuka Unveils Unprecedented Phase 3 VISIONARY Two-Year eGFR Results Demonstrating VOYXACT® (sibeprenlimab-szsi) Stabilizes Kidney Function Decline to Baseline Physiologic Rate, Fundamentally Altering Disease Progression in IgA Nephropathy - Business Wire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Sibeprenlimab.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.